Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5) : A Randomized Trial

CONCLUSION: Compared with OD analogues, icodec with app showed superior HbA1c reduction and improved treatment satisfaction and compliance with similarly low hypoglycemia rates.PRIMARY FUNDING SOURCE: Novo Nordisk A/S.PMID:37748181 | DOI:10.7326/M23-1288

Source: Annals of Internal Medicine - September 25, 2023 Category: Internal Medicine Authors: Harpreet S Bajaj Jens Aberle Melanie Davies Anders Meller Donatsky Marie Frederiksen Dilek G Yavuz Amoolya Gowda Ildiko Lingvay Bruce Bode Source Type: research